Literature DB >> 11988612

Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities.

Sean Ruland1, Philip B Gorelick, Michael Schneck, Duk Kim, Charity G Moore, Sue Leurgans.   

Abstract

BACKGROUND AND
PURPOSE: To define areas for quality improvement in acute stroke care, a statewide assessment of preparedness for acute stroke diagnosis and treatment was carried out among 202 acute receiving hospitals in Illinois.
METHODS: Medical directors or their designees completed a 1-page survey form that addressed availability of personnel, diagnostic technology, and organized programs for the treatment of acute stroke patients at their facility. In the analysis, acute care receiving hospitals in the Greater Chicago Metropolitan Area (GCMA) (Cook, Dupage, Lake, Will, and Kane counties) were compared with those in the remainder of the state.
RESULTS: Of the acute care receiving hospitals, 91% responded to the survey. Overall, 99% had an emergency room receiving facility, 98.3% had a CT scanner, and slightly >70% had a recombinant tissue plasminogen activator (r-TPA) protocol. We found that 93.2% of residents in Illinois lived in a county with at least 1 acute care facility with an r-TPA treatment protocol. However, many of the non-GCMA receiving hospitals did not have a neurologist or a neurosurgeon available. Furthermore, specialized stroke diagnostic technology (eg, transcranial Doppler, diffusion-weighted MRI, MR angiography) was generally lacking in both the GCMA and non-GCMA, as were stroke community awareness programs and acute care stroke teams.
CONCLUSIONS: Stroke is a preventable and treatable disease. However, there are barriers to stroke care that are based on the availability of personnel, diagnostic technology, and programs. A systematic approach to the organization, implementation, and maintenance of services could improve outcome for stroke patients and reduce the public health burden of this deadly disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988612     DOI: 10.1161/01.str.0000014609.44258.ad

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Prospects for acute stroke-- what can intensive care medicine offer?

Authors:  Peter J D Andrews
Journal:  Intensive Care Med       Date:  2003-06-18       Impact factor: 17.440

2.  30-Day risk-standardized mortality and readmission rates after ischemic stroke in critical access hospitals.

Authors:  Judith H Lichtman; Erica C Leifheit-Limson; Sara B Jones; Yun Wang; Larry B Goldstein
Journal:  Stroke       Date:  2012-08-30       Impact factor: 7.914

Review 3.  Improving Regional Stroke Systems of Care.

Authors:  Melissa S Eng; Anand V Patel; Richard B Libman; Paul Wright; Jeffrey M Katz
Journal:  Curr Atheroscler Rep       Date:  2017-10-24       Impact factor: 5.113

4.  Echocardiogram utilization among rural and urban veterans.

Authors:  Kingston Okrah; Mary Vaughan-Sarrazin; Peter Kaboli; Peter Cram
Journal:  J Rural Health       Date:  2011-05-25       Impact factor: 4.333

Review 5.  Organization of regional and local stroke resources: methods to expedite acute management of stroke.

Authors:  James Kennedy; Christina Ma; Alastair M Buchan
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

Review 6.  Development of regional programs to speed treatment of stroke.

Authors:  Jeffrey A Switzer; David C Hess
Journal:  Curr Neurol Neurosci Rep       Date:  2008-01       Impact factor: 5.081

Review 7.  Safety issues and concerns for the neurological patient in the emergency department.

Authors:  Edward M Manno
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Primary stroke center concept: strengths and limitations.

Authors:  Farrukh Salim Chaudhry; Michael J Schneck; J Warady; J Platakis; Sarkis Gibran Morales-Vidal; Jose Biller; M Flaster
Journal:  Front Neurol       Date:  2012-07-18       Impact factor: 4.003

Review 9.  Primary and comprehensive stroke centers: history, value and certification criteria.

Authors:  Philip B Gorelick
Journal:  J Stroke       Date:  2013-05-31       Impact factor: 6.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.